Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SENSAI: Seeing, hEaring, seNsing: Smart, Effortless and Objective Pain Assessment With Mobile AI Technology - DataBase Development

NCT07262632 is registered in ClinicalTrials.gov with Dr. Mark Mulder as lead sponsor.

NCT NCT07262632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07262632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SENSAI: Seeing, hEaring, seNsing: Smart, Effortless and Objective Pain Assessment With Mobile AI Technology - DataBase Development
Lead sponsor
Dr. Mark Mulder
Phase
Observational
Overall status
Recruiting
Start date
December 1, 2025
Completion date
December 31, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence (ai), cancer, cancer-related pain, database, facial expression, oncology, oncology pain, pain assessment, voice